Unsubscribe | View online | Report Spam
Too many emails? Get just one newsletter per day - Morning / Evening / CEO Picks













?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng
?
?
Learn more about Jeeng













You Might Like
? ?
?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


Want to accelerate software development at your company? See how we can help.
Want to accelerate software development at your company? See how we can help.














?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng
?
?
Learn more about Jeeng













You Might Like
? ?
?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...





Want to accelerate software development at your company? See how we can help.
Want to accelerate software development at your company? See how we can help.

Regulators Are Finally Catching Up With Big Tech - WIRED (Full Access)   

In 2024, we will see courts and regulators around the world demonstrate that tech exceptionalism, when it comes to the applicability of legal rules, is magical thinking. The tide has already started to turn on the assumption that law and regulation cannot keep up with technological innovation. But, in 2024, the sea change will come: not through new rules, but by old rules being applied aggressively to new problems.

In the United States, in the absence of federal privacy legislation, regulators have already started to repurpose laws and rules they do have at their disposal to address some of the most egregious examples of Big Tech playing fast and loose with our rights and personal data. In 2023, the US Federal Trade Commission (FTC) continued to expand the regulatory heft of consumer protection regulations.

It took on the problem of dark patterns—deceptive design used by apps and websites to trick users into doing something that they didn’t intend to, like buying or subscribing to something—with a half-billion-dollar fine against Fortnite maker Epic Games. The FTC also issued massive fines to Amazon for significant breaches of privacy through Alexa and Ring doorbell devices. There are no signs that, in 2024, the FTC will slow down, with rules in the pipeline to govern commercial surveillance and digital security. In 2024, we’ll see regulators in other fields and other parts of the world follow suit, bolstered by the FTC’s successes.

Continued here















?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng
?
?
Learn more about Jeeng













You Might Like
? ?
?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


You Know It’s a Placebo. So Why Does It Still Work? - WIRED (Full Access)   

You booked this doctor's appointment weeks in advance. You took off work, endured the trip here, filled out paperwork while a cooking show blared from a TV on the wall, and now you're finally in the inner sanctum, awkwardly perched on an exam table and staring at a jar of tongue depressors. Your doctor comes in, listens as you describe what's been bothering you. She nods, a wrinkle of concern crossing her forehead. She asks a few follow-up questions. Then she says, "I'm going to prescribe you something that isn't designed to treat these symptoms but may help you feel better. It's a placebo."

No doubt you're confused. Placebos famously rely on deception: You, the patient, receive an inert substance that you believe to be active and are fooled into feeling better. The word placebo comes from the Latin placere, "to please" (as in "more to please than benefit the patient," according to one 19th-century medical dictionary). How does your doctor expect you to be pleased, much less relieved of your symptoms, by a prescription for sugar pills? Is she a quack?

Fortunately, the answer is probably not. Many doctors—perhaps as many as 97 percent, according to a 2018 survey—prescribe placebos at some point in their careers. The American Medical Association green-lights placebo use as long as the patient is informed and consents; they need not be aware of when they're getting a placebo, only that it may be among the treatments. (The Hippocratic oath says, "Do no harm" not "Tell the whole truth.") A typical doctor might prescribe antibiotics even though the patient has a viral infection, or vitamin supplements even though there's no deficiency. What's different about your doctor is that she's letting you in on the secret. She's prescribing a so-called open-label placebo.

Continued here
















?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng
?
?
Learn more about Jeeng













You Might Like
? ?
?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...



















?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng

?
Learn more about Jeeng
?
?
Learn more about Jeeng













You Might Like
? ?
?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...

?
Learn more about RevenueStripe...


You are receiving this mailer as a TradeBriefs subscriber.
We fight fake/biased news through human curation & independent editorials.
Your support of ads like these makes it possible. Alternatively, get TradeBriefs Premium (ad-free) for only $2/month
If you still wish to unsubscribe, you can unsubscribe from all our emails here
Our address is 309 Town Center 1, Andheri Kurla Road, Andheri East, Mumbai 400059 - 93544947